{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:02:03Z","timestamp":1784736123192,"version":"3.55.0"},"reference-count":85,"publisher":"Elsevier","isbn-type":[{"value":"9780443470868","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.enz.2026.05.008","type":"book-chapter","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:29:36Z","timestamp":1782386976000},"page":"155-175","source":"Crossref","is-referenced-by-count":0,"title":["Carbonic anhydrase VII: Development of selective inhibitors and their pharmacological significance"],"prefix":"10.1016","author":[{"given":"Chandra Bhushan","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.enz.2026.05.008_bib0001","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/bs.enz.2026.05.008_bib0002","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/bs.enz.2026.05.008_bib0003","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1517\/17425255.2.1.113","article-title":"A perspective on quantitative structure-activity relationships and carbonic anhydrase inhibitors","volume":"2","author":"Clare","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/bs.enz.2026.05.008_bib0004","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/bs.enz.2026.05.008_bib0005","series-title":"Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications","year":"2009"},{"key":"10.1016\/bs.enz.2026.05.008_bib0006","series-title":"Carbonic Anhydrase: Its Inhibitors and Activators","year":"2004"},{"key":"10.1016\/bs.enz.2026.05.008_bib0007","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1152\/physrev.1967.47.4.595","article-title":"Carbonic anhydrase: chemistry, physiology and inhibition","volume":"47","author":"Maren","year":"1967","journal-title":"Physiol. Rev."},{"key":"10.1016\/bs.enz.2026.05.008_bib0008","series-title":"Carbonic Anhydrases as Biocatalysts: From Theory to Medical and Industrial Applications","year":"2015"},{"key":"10.1016\/bs.enz.2026.05.008_bib0009","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.biochi.2010.05.008","article-title":"Analysis of a shortened form of human carbonic anhydrase VII expressed in vitro compared to the full-length enzyme","volume":"92","author":"Bootorabi","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/bs.enz.2026.05.008_bib0010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1517\/13543776.14.5.667","article-title":"Modulation of carbonic anhydrase activity and its applications in therapy","volume":"14","author":"Scozzafava","year":"2004","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/bs.enz.2026.05.008_bib0011","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1523\/JNEUROSCI.5176-03.2004","article-title":"Carbonic anhydrase isoform VII acts as a molecular switch in the development of synchronous gamma-frequency firing of hippocampal CA1 pyramidal cells","volume":"24","author":"Ruusuvuori","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.enz.2026.05.008_bib0012","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1747-0285.2009.00857.x","article-title":"Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates?","volume":"74","author":"De Simone","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/bs.enz.2026.05.008_bib0013","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/cmdc.201000044","article-title":"Identification of potent and selective human carbonic anhydrase VII (hCA VII) inhibitors","volume":"5","author":"Gitto","year":"2010","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0014","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2188147","article-title":"Antihistamines, phenothiazine-based antipsychotics, and tricyclic antidepressants potently activate pharmacologically relevant human carbonic anhydrase isoforms II and VII","volume":"38","author":"Fiorentino","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0015","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1016\/j.bmc.2016.05.064","article-title":"Microwave assisted synthesis of novel acridine-acetazolamide conjugates and investigation of their inhibition effects on human carbonic anhydrase isoforms hCA I, II, IV and VII","volume":"24","author":"Ulus","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116279","article-title":"Design, synthesis and biochemical evaluation of novel carbonic anhydrase inhibitors triggered by structural knowledge on hCA VII","volume":"44","author":"Mancuso","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0017","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.bmcl.2010.07.051","article-title":"Crystal structure of the C183S\/C217S mutant of human CA VII in complex with acetazolamide","volume":"20","author":"Di Fiore","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.05.008_bib0018","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.1984.tb12314.x","article-title":"Structure, refinement, and function of carbonic anhydrase isozymes: refinement of human carbonic anhydrase I","volume":"429","author":"Kannan","year":"1984","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.enz.2026.05.008_bib0019","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/prot.340040406","article-title":"Refined structure of human carbonic anhydrase II at 2.0 \u00c5 resolution","volume":"4","author":"Eriksson","year":"1988","journal-title":"Proteins"},{"key":"10.1016\/bs.enz.2026.05.008_bib0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/prot.340160104","article-title":"Refined structure of bovine carbonic anhydrase III at 2.0 \u00c5 resolution","volume":"16","author":"Eriksson","year":"1993","journal-title":"Proteins"},{"key":"10.1016\/bs.enz.2026.05.008_bib0021","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1021\/bi050610h","article-title":"Human carbonic anhydrase III: structural and kinetic study of catalysis and proton transfer","volume":"44","author":"Duda","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/bs.enz.2026.05.008_bib0022","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1073\/pnas.93.24.13589","article-title":"Crystal structure of the secretory form of membrane-associated human carbonic anhydrase IV at 2.8 \u00c5 resolution","volume":"93","author":"Stams","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.enz.2026.05.008_bib0023","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1021\/acs.jcim.2c00910","article-title":"Identification of new carbonic anhydrase VII inhibitors by structure-based virtual screening","volume":"62","author":"Gantner","year":"2022","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/bs.enz.2026.05.008_bib0024","doi-asserted-by":"crossref","first-page":"10949","DOI":"10.1073\/pnas.92.24.10949","article-title":"Structure determination of murine mitochondrial carbonic anhydrase V at 2.45-A resolution: implications for catalytic proton transfer and inhibitor design","volume":"92","author":"Boriack-Sjodin","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.enz.2026.05.008_bib0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2012.02.038","article-title":"Crystal structure of the secretory isozyme of mammalian carbonic anhydrases CA VI: implications for biological assembly and inhibitor development","volume":"419","author":"Pilka","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.enz.2026.05.008_bib0026","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.enz.2026.05.008_bib0027","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.enz.2026.05.008_bib0028","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/bip.22456","article-title":"The structural comparison between membrane-associated human carbonic anhydrases provides insights into drug design of selective inhibitors","volume":"101","author":"Alterio","year":"2014","journal-title":"Biopolymers"},{"key":"10.1016\/bs.enz.2026.05.008_bib0029","doi-asserted-by":"crossref","first-page":"30766","DOI":"10.1074\/jbc.M805353200","article-title":"Entrapment of carbon dioxide in the active site of carbonic anhydrase II","volume":"283","author":"Domsic","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0030","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/ja00002a004","article-title":"CO2 binding to human carbonic anhydrase II","volume":"113","author":"Merz","year":"1991","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/bs.enz.2026.05.008_bib0031","unstructured":"World Health Organization, http:\/\/www.who.int\/mediacentre\/factsheets\/fs999\/en (Accessed 15 June 2020)."},{"key":"10.1016\/bs.enz.2026.05.008_bib0032","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/bs.enz.2026.05.008_bib0033","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.2174\/1381612822666160226144200","article-title":"Polypharmacological drugs in the treatment of epilepsy: the comprehensive review of marketed and new emerging molecules","volume":"22","author":"Kumari","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/bs.enz.2026.05.008_bib0034","series-title":"The Carbonic Anhydrases: New Horizons","first-page":"79","article-title":"An overview of the distribution and function of carbonic anhydrase in mammals","author":"Parkkila","year":"2000"},{"key":"10.1016\/bs.enz.2026.05.008_bib0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuint.2005.08.007","article-title":"Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus","volume":"48","author":"Halmi","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/bs.enz.2026.05.008_bib0036","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0165-3806(93)90200-T","article-title":"Developmental changes in seizure susceptibility in carbonic anhydrase II-deficient mice and normal littermates","volume":"72","author":"Velisek","year":"1993","journal-title":"Dev. Brain Res."},{"key":"10.1016\/bs.enz.2026.05.008_bib0037","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eplepsyres.2008.09.008","article-title":"Bicarbonate contributes to GABAA receptor-mediated neuronal excitation in surgically resected human hypothalamic hamartomas","volume":"83","author":"Kim","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/bs.enz.2026.05.008_bib0038","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/emboj.2013.160","article-title":"Neuronal carbonic anhydrase VII provides GABAergic excitatory drive to exacerbate febrile seizures","volume":"32","author":"Ruusuvuori","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/bs.enz.2026.05.008_bib0039","doi-asserted-by":"crossref","first-page":"9902","DOI":"10.1016\/S0021-9258(18)48019-2","article-title":"Protein damage and degradation by oxygen radicals. II. Modification of amino acids","volume":"262","author":"Davies","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0040","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.bmcl.2011.12.134","article-title":"Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors","volume":"22","author":"Truppo","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.05.008_bib0041","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-5793(00)02022-6","article-title":"Crystal structure of S-glutathiolated carbonic anhydrase III","volume":"482","author":"Mallis","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/bs.enz.2026.05.008_bib0042","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1515\/hsz-2013-0204","article-title":"Human carbonic anhydrase VII protects cells from oxidative damage","volume":"394","author":"Del Giudice","year":"2013","journal-title":"Biol. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0043","series-title":"Carbonic Anhydrases as Biocatalysts","first-page":"151","article-title":"Carbonic Anhydrase VII","author":"Monti","year":"2015"},{"key":"10.1016\/bs.enz.2026.05.008_bib0044","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.3390\/molecules26216380","article-title":"Carbonic Anhydrase inhibitors and epilepsy: state of the art and future perspectives","volume":"26","author":"Ciccone","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/bs.enz.2026.05.008_bib0045","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1007\/s11064-021-03390-2","article-title":"Anticonvulsant effects of carbonic anhydrase inhibitors: the enigmatic link between carbonic anhydrases and electrical activity of the brain","volume":"46","author":"Ozsoy","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/bs.enz.2026.05.008_bib0046","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/14756366.2016.1197221","article-title":"Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl\/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors","volume":"31","author":"Mishra","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0047","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1021\/acs.jmedchem.6b01804","article-title":"Discovery of benzenesulfonamides with potent human carbonic anhydrase inhibitory and effective anticonvulsant action: design, synthesis, and pharmacological assessment","volume":"60","author":"Mishra","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0048","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.bmc.2016.01.012","article-title":"Sulfamide derivatives with selective carbonic anhydrase VII inhibitory action","volume":"24","author":"Villalba","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0049","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejmech.2018.07.019","article-title":"Discovery of potent anti-convulsant carbonic anhydrase inhibitors: design, synthesis, in vitro and in vivo appraisal","volume":"156","author":"Mishra","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0050","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1021\/acs.jmedchem.7b00264","article-title":"Probing molecular interactions between human carbonic anhydrasess (hCAs) and a novel class of benzenesulfonamides","volume":"60","author":"Bruno","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0051","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/acsmedchemlett.7b00300","article-title":"Lucky switcheroo: dramatic potency and selectivity improvement of imidazoline inhibitors of human carbonic anhydrase VII","volume":"8","author":"Kalinin","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.05.008_bib0052","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/acsmedchemlett.7b00387","article-title":"Synthesis of novel selenides bearing benzenesulfonamide moieties as carbonic anhydrase I, II, IV, VII, and IX inhibitors","volume":"8","author":"Angeli","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.05.008_bib0053","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/acsmedchemlett.8b00076","article-title":"Design, synthesis, and x-ray of selenides as new class of agents for prevention of diabetic cerebrovascular pathology","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.05.008_bib0054","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bmc.2015.11.034","article-title":"Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide\/phthalic anhydride scaffolds","volume":"24","author":"El-Azab","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0055","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1016\/j.bmc.2015.10.018","article-title":"New natural product carbonic anhydrase inhibitors incorporating phenol moieties","volume":"23","author":"Karioti","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0056","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1021\/acs.jmedchem.8b00208","article-title":"Discovery of benzenesulfonamide derivatives as carbonic anhydrase inhibitors with effective anticonvulsant action: design, synthesis, and pharmacological evaluation","volume":"61","author":"Mishra","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0057","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1021\/acs.jmedchem.0c01889","article-title":"Discovery of potent carbonic anhydrase inhibitors as effective anticonvulsant agents: drug design, synthesis, and in vitro and in vivo investigations","volume":"64","author":"Mishra","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106725","article-title":"4-Cyanamido-substituted benzenesulfonamides act as dual carbonic anhydrase and cathepsin inhibitors","volume":"139","author":"Abdoli","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0059","article-title":"Sultam based carbonic anhydrase VII inhibitors for the management of neuropathic pain","volume":"227","author":"D\u2019Ambrosio","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0060","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2174981","article-title":"2-((1H-Benzo[d]imidazol-2-yl)amino)benzo[d]thiazole-6-sulphonamides: a class of carbonic anhydrase II and VII-selective inhibitors","volume":"38","author":"Abdoli","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0061","doi-asserted-by":"crossref","first-page":"8118","DOI":"10.1021\/acs.jmedchem.3c00433","article-title":"6-Substituted triazolyl benzoxaboroles as selective carbonic anhydrase inhibitors: in silico design, synthesis, and x-ray crystallography","volume":"66","author":"Nocentini","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0062","doi-asserted-by":"crossref","first-page":"26280","DOI":"10.1021\/acs.jmedchem.5c02403","article-title":"Identification of benzenesulfonamide-containing thiazolidine-2,4-dione derivatives as novel carbonic anhydrase II and VII inhibitors with anti-epileptic activity","volume":"68","author":"Eldesouki","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0063","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1021\/acs.jmedchem.5c00526","article-title":"Shooting an arrow against convulsion: novel triazole-grafted benzenesulfonamide derivatives as carbonic anhydrase II and VII inhibitors","volume":"68","author":"Zeidan","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117706","article-title":"Development of isatin-functionalized benzenesulfonamides as novel carbonic anhydrase II and VII inhibitors with antiepileptic potential","volume":"292","author":"Eldehna","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129411","article-title":"A simple yet multifaceted 90 years old, evergreen enzyme: carbonic anhydrase, its inhibition and activation","volume":"93","author":"Supuran","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.05.008_bib0066","doi-asserted-by":"crossref","DOI":"10.1124\/pharmrev.124.001125","article-title":"Multi- and polypharmacology of carbonic anhydrase inhibitors","volume":"77","author":"Supuran","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/bs.enz.2026.05.008_bib0067","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1021\/acsmedchemlett.5c00443","article-title":"Human carbonic anhydrase inhibitors","volume":"16","author":"Supuran","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.05.008_bib0068","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1326633","article-title":"Carbonic anhydrase versatility: from pH regulation to CO2 sensing and metabolism","volume":"10","author":"Supuran","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/bs.enz.2026.05.008_bib0069","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acs.chemrev.4c00278","article-title":"Multiple binding modes of inhibitors to human carbonic anhydrases: an update on the design of isoform-specific modulators of activity","volume":"125","author":"D\u2019Ambrosio","year":"2025","journal-title":"Chem. Rev."},{"issue":"5","key":"10.1016\/bs.enz.2026.05.008_bib0070","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4155\/fmc-2017-0223","article-title":"Carbonic anhydrase activators","volume":"10","author":"Supuran","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0071","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jps.2600830603","article-title":"Carbonic anhydrase activators. 3: structure-activity correlations for a series of isozyme II activators","volume":"83","author":"Clare","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/bs.enz.2026.05.008_bib0072","first-page":"107","article-title":"Carbonic anhydrase activators. Part 8. pKa\u2014activation relationship in a series of amino acid derivatives activators of isozyme II","volume":"39","author":"Supuran","year":"1994","journal-title":"Rev. Roum. Chim."},{"issue":"23","key":"10.1016\/bs.enz.2026.05.008_bib0073","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1016\/j.bmcl.2005.08.069","article-title":"Carbonic anhydrase activators: x-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators","volume":"15","author":"Temperini","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"27","key":"10.1016\/bs.enz.2026.05.008_bib0074","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1002\/chem.200600159","article-title":"Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme","volume":"12","author":"Temperini","year":"2006","journal-title":"Chemistry"},{"issue":"10","key":"10.1016\/bs.enz.2026.05.008_bib0075","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/jm0603320","volume":"49","author":"Temperini","year":"2006","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/bs.enz.2026.05.008_bib0076","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.1016\/j.bmc.2008.08.043","article-title":"Carbonic anhydrase activators: kinetic and x-ray crystallographic study for the interaction of D- and L-tryptophan with the mammalian isoforms I-XIV","volume":"16","author":"Temperini","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/bs.enz.2026.05.008_bib0077","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bmcl.2006.11.027","article-title":"Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV","volume":"17","author":"Temperini","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"15","key":"10.1016\/bs.enz.2026.05.008_bib0078","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1016\/j.bmcl.2007.05.052","article-title":"Carbonic anhydrase activators: activation of the human isoforms VII (cytosolic) and XIV (transmembrane) with amino acids and amines","volume":"17","author":"Vullo","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/bs.enz.2026.05.008_bib0079","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/14656566.2025.2474574","article-title":"Polypharmacology of carbonic anhydrase inhibitors and activators","volume":"26","author":"Bonardi","year":"2025","journal-title":"Expert Opin. Pharmacother"},{"issue":"8","key":"10.1016\/bs.enz.2026.05.008_bib0080","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.70272","article-title":"A new series of amino alcohol oxime ethers as activators of human brain carbonic anhydrases: advances in selective activation of human carbonic anhydrase VII","volume":"21","author":"Mangini","year":"2026","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/bs.enz.2026.05.008_bib0081","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1080\/14756366.2020.1766455","article-title":"Carbonic anhydrase modulation of emotional memory. Implications for the treatment of cognitive disorders","volume":"35","author":"Blandina","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2026.05.008_bib0082","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/14756366.2021.1891051","article-title":"Activation of carbonic anhydrase isoforms involved in modulation of emotional memory and cognitive disorders with histamine agonists, antagonists and derivatives","volume":"36","author":"Provensi","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"27","key":"10.1016\/bs.enz.2026.05.008_bib0083","doi-asserted-by":"crossref","first-page":"16000","DOI":"10.1073\/pnas.1910690117","article-title":"The role of carbonic anhydrases in extinction of contextual fear memory","volume":"117","author":"Schmidt","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.enz.2026.05.008_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114828","article-title":"New \u03b2-arylchalcogeno amines with procognitive properties targeting carbonic anhydrases and Monoamine Oxidases","volume":"244","author":"Provensi","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.05.008_bib0085","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuroscience.2022.03.025","article-title":"Modulation of carbonic anhydrases activity in the hippocampus or prefrontal cortex differentially affects social recognition memory in rats","volume":"497","author":"Schmidt","year":"2022","journal-title":"Neuroscience"}],"container-title":["The Enzymes","Vertebrate Carbonic Anhydrases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604726000132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604726000132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:14:27Z","timestamp":1784733267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874604726000132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443470868"],"references-count":85,"URL":"https:\/\/doi.org\/10.1016\/bs.enz.2026.05.008","relation":{},"ISSN":["1874-6047"],"issn-type":[{"value":"1874-6047","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}